Tesla
TSLA
Netflix
NFLX
Disney
DIS
4
Cisco
CSCO
5
Meta Platforms
META
US Stock MarketDetailed Quotes
MREO Mereo BioPharma
- 2.520
- -0.090-3.45%
Close Apr 29 16:00 ET
- 2.520
- 0.0000.00%
Post 20:01 ET
400.68MMarket Cap-8.40P/E (TTM)
2.650High2.520Low375.07KVolume2.600Open2.610Pre Close954.42KTurnover0.40%Turnover RatioLossP/E (Static)159.00MShares5.02052wk High6.58P/B237.72MFloat Cap1.57552wk Low--Dividend TTM94.33MShs Float8.480Historical High--Div YieldTTM4.98%Amplitude0.301Historical Low2.544Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
Mereo BioPharma Stock Forum
Mereo BioPharma Secures 3-Year Cash Runway While Pushing Phase 3 Studies Forward
Larger Image: tradingview.com...
$Mereo BioPharma (MREO.US)$
Mereo spikes after mid-stage data for Ultragenyx-partnered bone disorder therapy
$Merck & Co (MRK.US)$ x $Immunovant (IMVT.US)$
$Eli Lilly and Co (LLY.US)$ x $Cytokinetics (CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals (REGN.US)$ x $Apellis Pharmaceuticals (APLS.US)$ (panache & brash)
$Gilead Sciences (GILD.US)$ x % $Madrigal Pharmaceuticals (MDGL.US)$ (liver king)
$Bristol-Myers Squibb (BMY.US)$ x $Iovance Biotherapeutics (IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co (LLY.US)$ x $Merus (MRUS.US)$ (partner n...
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
No comment yet